Skip navigation
Agenda

Collaborative Approaches for Risk Sharing, Population Health Management and Data-Driven Product-Advancement

March 27-28, 2018
  • Scottsdale, AZ

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, MARCH 27, 2018

7:30

Registration and Continental Breakfast

8:30

Co-Chair Welcome and Opening Remarks

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

8:45

TRAILBLAZER PANEL DISCUSSION A Bird’s Eye View of the Rise of IDNs and the Emerging Healthcare Paradigm

MODERATOR:

Jasmine Carvalho
Manager, Innovation
Zitter Health Insights

PANELISTS:

Kyle Skiermont
PharmD,Chief Operating Officer
Fairview Pharmacy Services

Jeff Prewett
Senior National Account Director - Oncology GPO & IDN
Lilly USA, LLC

9:45

ROCHE CASE STUDY Salesforce 2.0 — Using Behavior Science to Enhance Your Salesforce

Jay Graves
Vice President, Sales
Roche Diabetes Care Inc.

10:30

Networking and Refreshment Break

11:00

PANEL DISCUSSION Biosimilars from the Health System Perspective

MODERATOR:

Gerard Taglianetti
Director, Team Leader U.S. Payer & Channel Access
Pfizer Inc

PANELISTS:

Patti Hawkins
Director, Outpatient Infusion, Home & Specialty Pharmacy Services, 340B Program Manager
North Mississippi Medical Center

Karen Purgett, MBA
Pharmacy Business Services Manager, Pharmacy Administration
Marshfield Clinic

11:45

Integrated Delivery Networks and Pharma —
Same Mission, So Why the Conflict?

Jody Miller, MBA
President, Ambulatory & Specialty Pharmacy
Comprehensive Pharmacy Services

12:30

Networking Luncheon

1:30

PRESENTATION AND DISCUSSIONUncover the Challenges of Specialty Data Management within the
IDN Environment

Lonnie Smith, PharmD
Manager, Specialty Pharmacy Services
University of Utah Health

2:15

Bridge the Gaps and Plan Ahead for Success in the Health System Market

Christopher Lisanti
Managing Partner
Exequor Group

Greg Allard
Partner
Exequor Group

3:00

Networking and Refreshment Break

3:30

Follow the Patient Journey through an IDN — From Diagnosis to Treatment

Amy H. Seung, PharmD
BCOP, Senior Director, Clinical Development
AssistRx

4:15

Developing Real World Outcomes — Where BioPharma and IDNs Intersect

Scot Buchanan
VP, Biotech and Specialty Services
Therigy LLC

Rich Gourash
VP, Specialty Outcomes
Therigy LLC

5:00

PANEL DISCUSSION Build a Robust Value Proposition —
Connecting Decisions with Cost-Saving Evidence and Better Patient Outcomes

MODERATOR:

William Roth
Founding Partner
Blue Fin Group

PANELISTS:

Aria Cohen
Executive Director, Payer Strategy & Operations
Intarcia Therapeutics, Inc.

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

Marc O’Connor
Principal, Chief Operating Officer
Curant Health

5:45

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO WEDNESDAY, MARCH 28, 2018

8:15

Continental Breakfast

8:45

Co-Chair Review of Day One

Gerard Taglianetti
Director, Team Leader U.S. Payer & Channel Access
Pfizer Inc

9:15

Patterns of Treatment Influence in Integrated Delivery Networks

Rory Martin, PhD
COE Leader, Integrated Delivery Networks
IQVIA

10:00

IDN-Specialty Pharmacies —
Overcoming the Challenges of Limited Distribution Networks

Melissa Skelton Duke
Senior Director, Ambulatory Pharmacy Services
Banner Health

10:45

Networking and Refreshment Break

11:15

A Spotlight on Medicare Payment Reform for Key Stakeholders

Ira Klein
Senior Director, Quality, Strategic Customer Group
Janssen

12:00

Networking Luncheon

1:00

Examine the Role of the EHR within the IDN Ecosystem

Brian Bamberger
Life Sciences Practice Lead
Point-of-Care Partners

1:45

IDNs and Channels with a Small Sales Force in the Generic Injectable Market

Jeremy Tatum
Director of Sales and Strategic Accounts
American Regent

Jeremy Tatum
Director of Sales and Strategic Accounts
American Regent

2:30

Closing Discussion with the Chairmen

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

Josh Hayer, MBA
Associate Director, Corporate Institutional Sales
Anda Inc.

2:40

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, MARCH 27, 2018

7:30

Registration and Continental Breakfast

8:30

Co-Chair Welcome and Opening Remarks

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

8:45

TRAILBLAZER PANEL DISCUSSION A Bird’s Eye View of the Rise of IDNs and the Emerging Healthcare Paradigm

MODERATOR:

Jasmine Carvalho
Manager, Innovation
Zitter Health Insights

PANELISTS:

Kyle Skiermont
PharmD,Chief Operating Officer
Fairview Pharmacy Services

Jeff Prewett
Senior National Account Director - Oncology GPO & IDN
Lilly USA, LLC

9:45

ROCHE CASE STUDY Salesforce 2.0 — Using Behavior Science to Enhance Your Salesforce

Jay Graves
Vice President, Sales
Roche Diabetes Care Inc.

10:30

Networking and Refreshment Break

11:00

PANEL DISCUSSION Biosimilars from the Health System Perspective

MODERATOR:

Gerard Taglianetti
Director, Team Leader U.S. Payer & Channel Access
Pfizer Inc

PANELISTS:

Patti Hawkins
Director, Outpatient Infusion, Home & Specialty Pharmacy Services, 340B Program Manager
North Mississippi Medical Center

Karen Purgett, MBA
Pharmacy Business Services Manager, Pharmacy Administration
Marshfield Clinic

11:45

Integrated Delivery Networks and Pharma —
Same Mission, So Why the Conflict?

Jody Miller, MBA
President, Ambulatory & Specialty Pharmacy
Comprehensive Pharmacy Services

12:30

Networking Luncheon

1:30

PRESENTATION AND DISCUSSIONUncover the Challenges of Specialty Data Management within the
IDN Environment

Lonnie Smith, PharmD
Manager, Specialty Pharmacy Services
University of Utah Health

2:15

Bridge the Gaps and Plan Ahead for Success in the Health System Market

Christopher Lisanti
Managing Partner
Exequor Group

Greg Allard
Partner
Exequor Group

3:00

Networking and Refreshment Break

3:30

Follow the Patient Journey through an IDN — From Diagnosis to Treatment

Amy H. Seung, PharmD
BCOP, Senior Director, Clinical Development
AssistRx

4:15

Developing Real World Outcomes — Where BioPharma and IDNs Intersect

Scot Buchanan
VP, Biotech and Specialty Services
Therigy LLC

Rich Gourash
VP, Specialty Outcomes
Therigy LLC

5:00

PANEL DISCUSSION Build a Robust Value Proposition —
Connecting Decisions with Cost-Saving Evidence and Better Patient Outcomes

MODERATOR:

William Roth
Founding Partner
Blue Fin Group

PANELISTS:

Aria Cohen
Executive Director, Payer Strategy & Operations
Intarcia Therapeutics, Inc.

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

Marc O’Connor
Principal, Chief Operating Officer
Curant Health

5:45

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO WEDNESDAY, MARCH 28, 2018

8:15

Continental Breakfast

8:45

Co-Chair Review of Day One

Gerard Taglianetti
Director, Team Leader U.S. Payer & Channel Access
Pfizer Inc

9:15

Patterns of Treatment Influence in Integrated Delivery Networks

Rory Martin, PhD
COE Leader, Integrated Delivery Networks
IQVIA

10:00

IDN-Specialty Pharmacies —
Overcoming the Challenges of Limited Distribution Networks

Melissa Skelton Duke
Senior Director, Ambulatory Pharmacy Services
Banner Health

10:45

Networking and Refreshment Break

11:15

A Spotlight on Medicare Payment Reform for Key Stakeholders

Ira Klein
Senior Director, Quality, Strategic Customer Group
Janssen

12:00

Networking Luncheon

1:00

Examine the Role of the EHR within the IDN Ecosystem

Brian Bamberger
Life Sciences Practice Lead
Point-of-Care Partners

1:45

IDNs and Channels with a Small Sales Force in the Generic Injectable Market

Jeremy Tatum
Director of Sales and Strategic Accounts
American Regent

Jeremy Tatum
Director of Sales and Strategic Accounts
American Regent

2:30

Closing Discussion with the Chairmen

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

Josh Hayer, MBA
Associate Director, Corporate Institutional Sales
Anda Inc.

2:40

Close of Conference